Godrej Agrovet rejigs portfolio to improve earnings quality

Godrej Agrovet is entering a new phase of growth with a focus on earnings quality, capital efficiency and sustainable returns rather than revenue expansion alone.

Targeting cash‑rich, low‑volatility businesses to boost returns and earnings quality.

As Godrej Agrovet enters its next phase of growth, the company is placing greater emphasis on the quality and sustainability of earnings than on revenue expansion alone, reshaping its portfolio to improve returns on capital, reduce earnings volatility and strengthen long-term capital discipline.

Over the past two years, Godrej Agrovet has deployed nearly ₹1,750 crore towards acquisitions, subsidiary consolidation and capital expenditure while improving return on capital employed (ROCE) from 16 per cent to 20 per cent.

The ₹10,233-crore Godrej Industries Group company is sharpening its portfolio focus, with a greater emphasis on businesses that offer stronger growth visibility, higher value addition and better returns on capital. Investments are being directed towards premium animal nutrition, value-added dairy, branded foods, downstream oil palm.

The contract Development and Manufacturing Operations (CDMO) segment is highly relevant for Godrej Agrovet Ltd. (GAVL) as it provides a strategic transition away from cyclical commodity chemicals toward high-margin, stable, and long-term partnerships with global innovators. This segment is primarily executed through its subsidiary, Astec

According to company officials familiar with the strategy, the exercise is intended to improve returns on capital, reduce earnings volatility and focus management attention on businesses with stronger long-term growth potential.

The transformation comes as Godrej Agrovet reported consolidated revenue of ₹10,233 crore in FY26, crossing the ₹10,000-crore mark for the first time, while profit before tax before exceptional items rose 17.2 per cent to ₹569 crore. The company has guided for double-digit revenue growth and mid-double-digit profit growth in FY27.

Unlike earlier phases of expansion that relied largely on adding businesses and capacity, the current phase is being funded primarily through internal cash generation.

Company officials said businesses with limited growth potential, structurally weak profitability, or volatile earnings are being evaluated alongside opportunities capable of delivering stronger returns and more durable cash generation.

The portfolio review signals a broader change in how Godrej Agrovet intends to create value. Rather than assessing businesses primarily by their contribution to revenue, the company is increasingly prioritising earnings quality, return on capital and cash generation when allocating investment.

However industry analysts say, the larger challenge, however, will be execution, whether higher-margin businesses such as value-added dairy, branded foods, premium animal nutrition , downstream oil palm and CDMO can grow quickly enough to contribute a materially larger share of profits while reducing the company’s dependence on more volatile, commodity-linked businesses.